COPD exacerbations: definitions and classifications
Top Cited Papers
Open Access
- 1 June 2003
- journal article
- review article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 21 (41 suppl) , 46s-53s
- https://doi.org/10.1183/09031936.03.00078002
Abstract
Chronic obstructive pulmonary disease (COPD) is defined independently of exacerbations, which are largely a feature of moderate-to-severe disease. This article is the result of a workshop that tried to define exacerbations of COPD for use in clinical, pharmacological and epidemiological studies. The conclusions represent the consensus of those present.This review describes definitions, ascertainment, severity assessments, duration and frequency, using varying sources of data including direct patient interview, healthcare databases and symptom diaries kept by patients in studies.The best general definition of a COPD exacerbation is the following: an exacerbation of COPD is a sustained worsening of the patient's condition, from the stable state and beyond normal day-to-day variations that is acute in onset and may warrant additional treatment in a patient with underlying COPD.A more specific definition for studies where a bacteriological cause of exacerbation is being studied is included, as well as simpler definitions for retrospective identification from database sources. Prospective diary card assessments are best recorded as changes from an agreed baseline, rather than absolute symptom severities. Diary cards identify many unreported exacerbations, which on average have similar severities to reported exacerbations. A scale for exacerbation severity is proposed that incorporates in- and outpatient assessments. Exacerbation duration, which also relates to severity, is defined from diary card reports. Healthcare utilisation is not an adequate substitute for severity, depending on many unrelated social and comorbidity factors. It is an outcome in its own right.Keywords
This publication has 45 references indexed in Scilit:
- Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialThe Lancet, 2003
- Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective studyThe Lancet, 2001
- Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trialThe Lancet, 2000
- La enfermedad pulmonar obstructiva crónica y las estaciones del añoArchivos de Bronconeumología, 2000
- Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trialThe Lancet, 2000
- The Health and Economic Benefits Associated With Pneumococcal Vaccination of Elderly Persons With Chronic Lung DiseaseArchives of internal medicine (1960), 1999
- Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trialThe Lancet, 1999
- An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary diseaseRespiratory Medicine, 1999
- Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment serviceThe Lancet, 1998
- Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary diseaseThe Lancet, 1998